Nicholas J. Lowe
#145,182
Most Influential Person Now
Nicholas J. Lowe's AcademicInfluence.com Rankings
Nicholas J. Lowephilosophy Degrees
Philosophy
#7781
World Rank
#11036
Historical Rank
Logic
#4819
World Rank
#6148
Historical Rank
Nicholas J. Lowebiology Degrees
Biology
#10501
World Rank
#13834
Historical Rank
Immunology
#658
World Rank
#679
Historical Rank
Download Badge
Philosophy Biology
Why Is Nicholas J. Lowe Influential?
(Suggest an Edit or Addition)Nicholas J. Lowe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. (1999) (602)
- Recognition, diagnosis, and treatment of primary focal hyperhidrosis. (2004) (391)
- A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. (2002) (380)
- Adverse reactions to dermal fillers: review. (2005) (370)
- Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial (2001) (309)
- Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. (2003) (297)
- Hyaluronic acid skin fillers: adverse reactions and skin testing. (2001) (285)
- A randomized trial of etanercept as monotherapy for psoriasis. (2003) (256)
- Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? (2000) (234)
- Sunscreens : development, evaluation, and regulatory aspects (1990) (214)
- Skin Resurfacing with the Ultrapulse Carbon Dioxide Laser: Observations on 100 Patients (1995) (207)
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. (1999) (179)
- PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. (1986) (176)
- Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial (2002) (174)
- Tazarotene gel, a new retinoid, for topical therapy of psoriasis: vehicle-controlled study of safety, efficacy, and duration of therapeutic effect. (1997) (171)
- Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. (1991) (167)
- Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Palmar Hyperhidrosis: A Double‐Blind, Randomized, Placebo‐Controlled Study (2002) (163)
- Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. (2003) (160)
- Photodynamic Therapy: A Clinical Consensus Guide (2016) (158)
- Laser Skin Resurfacing with the Silk Touch Flashscanner for Facial Rhytides (1995) (147)
- Laser Resurfacing in Pigmented Skin (1995) (147)
- Adverse reactions to dermal fillers: A review of European experiences (2005) (147)
- Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study. (2003) (144)
- Laser Skin Resurfacing: Pre‐ and Posttreatment Guidelines (1995) (142)
- Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. (2007) (140)
- Arterial embolization caused by injection of hyaluronic acid (Restylane) (2003) (135)
- The use of photodynamic therapy in dermatology: results of a consensus conference. (2006) (131)
- Double‐Blind, Randomized, Placebo‐Controlled, Dose‐Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's Feet (2005) (127)
- Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. (1999) (124)
- Low doses of repetitive ultraviolet A induce morphologic changes in human skin. (1995) (122)
- Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail. (1998) (122)
- Adverse Effects of Retinoids (1988) (118)
- Flashlamp-pumped pulsed dye laser treatment of port-wine stains. (1994) (118)
- Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. (2003) (118)
- Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. (1996) (115)
- Models in dermatology (1987) (108)
- Anthralin: historical and current perspectives. (1983) (108)
- Long-term low-dose cyclosporine therapy for severe psoriasis: effects on renal function and structure. (1996) (107)
- Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet. (2002) (105)
- Induction of mouse epidermal ornithine decarboxylase activity and DNA synthesis by ultraviolet light. (1979) (101)
- Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences (2004) (97)
- CTLA 4 Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris (1999) (92)
- Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study. (2006) (91)
- Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema. (1991) (90)
- CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study. (2003) (89)
- Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies (2009) (88)
- Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. (2001) (88)
- Tazarotene plus UVB phototherapy in the treatment of psoriasis. (2000) (88)
- Ultraviolet radiation-induced connective tissue changes in the skin of hairless mice. (1984) (86)
- Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. (2002) (85)
- Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. (1998) (84)
- Topical photodynamic therapy in clinical dermatology (2004) (84)
- Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. (1998) (83)
- A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. (2010) (82)
- Botulinum Toxin Type A for Facial Rejuvenation: United States and United Kingdom Perspectives (1998) (82)
- Essential fatty acid deficient hairless mouse: a model of chronic epidermal hyperproliferation (1977) (81)
- Association of HLA-DR4 with vitiligo. (1983) (80)
- An overview of ultraviolet radiation, sunscreens, and photo-induced dermatoses. (2006) (77)
- Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy (2002) (76)
- Nevus of Ota: treatment with high energy fluences of the Q-switched ruby laser. (1993) (75)
- The place of botulinum toxin type A in the treatment of focal hyperhidrosis (2004) (71)
- Effects of acitretin on the liver. (1999) (70)
- Current systemic therapies for psoriasis: where are we now? (2003) (69)
- Photochemotherapy for mycosis fungoides: a clinical and histological study. (1979) (68)
- Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. (1983) (65)
- Coal tar phototherapy for psoriasis reevaluated: erythemogenic versus suberythemogenic ultraviolet with a tar extract in oil and crude coal tar. (1983) (65)
- Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis. (1985) (63)
- Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. (1986) (63)
- HL‐A antigens in lichen planus (1976) (63)
- Infmorbital Pigmented Skin: Preliminary Observations of Laser Therapy (1995) (61)
- Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanercept. (2006) (61)
- Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. (1998) (60)
- Botulinum toxin types A and B: comparison of efficacy, duration, and dose-ranging studies for the treatment of facial rhytides and hyperhidrosis. (2004) (59)
- The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study. (1995) (58)
- Histologic changes in the skin of the rhino mouse (hrrhhrrh) induced by retinoids. (1984) (58)
- Carbohydrate metabolism in lichen planus (1976) (57)
- Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing (2002) (57)
- Generalized pustular psoriasis precipitated by lithium carbonate. (1978) (57)
- A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. (2001) (57)
- Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin. (2001) (56)
- Pityriasis rubra pilaris. Further observations of systemic retinoid therapy. (1990) (56)
- Coexistence of lichen planus and systemic lupus erythematosus. (1982) (55)
- Cyclosporine as maintenance therapy in patients with severe psoriasis. (1997) (55)
- Mutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet light. (1981) (54)
- Comparisons among Botulinum Toxins: An Evidence-Based Review (2008) (54)
- Cutaneous polyamines in psoriasis (1982) (53)
- Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials. (1992) (53)
- Injectable poly-L-lactic acid for cosmetic enhancement: learning from the European experience. (2009) (52)
- Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept. (2006) (51)
- The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis. (1998) (51)
- A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. (2005) (49)
- Injectable Poly‐l‐Lactic Acid: 3 Years of Aesthetic Experience (2009) (49)
- The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. (1992) (49)
- Electron‐beam treatment of scleromyxoedema (1982) (49)
- A comparative study of the induction of epidermal hyperplasia by natural and synthetic retinoids. (1986) (49)
- A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis (2003) (49)
- Botulinum toxin type A gives adjunctive benefit to periorbital laser resurfacing (2004) (48)
- Flash lamp-pumped dye laser treatment of telangiectasia. (1993) (48)
- Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acne. (2004) (47)
- Efficacy and Pharmacokinetics of Two Formulations of Cyclosporine A in Patients with Psoriasis (1995) (47)
- Etretin therapy for severe psoriasis. Evaluation of initial clinical responses. (1987) (47)
- Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacy (2003) (46)
- Injectable Hyaluronic Acid Implant for Malar and Mental Enhancement (2006) (46)
- Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects. (1987) (45)
- Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction. (1983) (45)
- The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety. (2004) (45)
- Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis (2003) (45)
- Light‐emitting diode 415 nm in the treatment of inflammatory acne: An open‐label, multicentric, pilot investigation (2006) (45)
- A Comparison of Two Botulinum Type A Toxin Preparations for the Treatment of Glabellar Lines: Double‐Blind, Randomized, Pilot Study (2005) (45)
- Retinoid therapy for psoriasis. (2004) (42)
- Botulinum Toxin Type A in the Treatment of Bilateral Primary Axillary Hyperhidrosis: Efficacy and Duration With Repeated Treatments (2003) (42)
- Psoriasis therapy: comparative studies with a hydrocolloid dressing, plastic film occlusion, and triamcinolone acetonide cream. (1989) (42)
- Effects of topical prostaglandin E analogue on normal hairless mouse epidermal DNA synthesis. (1977) (40)
- Anthralin for psoriasis: short-contact anthralin therapy compared with topical steroid and conventional anthralin. (1984) (40)
- Long-Term Efficacy and Safety of Tretinoin Emollient Cream 0.05% in the Treatment of Photodamaged Facial Skin (2005) (40)
- Depletion of cutaneous glutathione and the induction of inflammation by 8-methoxypsoralen plus UVA radiation. (1986) (40)
- Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail. (1998) (39)
- Induction of ornithine decarboxylase activity and DNA synthesis in hairless mouse epidermis by retinoids. (1983) (38)
- Photoreactions with a fluoroquinolone antimicrobial: Evening versus morning dosing (1994) (37)
- Fish oil supplementation results in decreased hypertriglyceridemia in patients with psoriasis undergoing etretinate or acitretin therapy. (1988) (36)
- Cosmetic uses of botulinum toxins for lower aspects of the face and neck. (2004) (36)
- Percutaneous absorption in experimental epidermal disease (1979) (36)
- One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. (1997) (35)
- Anthralin. Different concentration effects on epidermal cell DNA synthesis rates in mice and clinical responses in human psoriasis. (1981) (35)
- The place of botulinum toxin type A in the treatment of focal hyperhidrosis: reply from authors (2005) (34)
- Etanercept therapy allows the tapering of methotrexate and sustained clinical responses in patients with moderate to severe psoriasis (2008) (34)
- Psoriasiform dermatosis in a rhesus monkey. (1981) (33)
- Optimizing poly‐l‐lactic acid use (2008) (33)
- Lasers and adjunctive treatments for facial scars: a review. (1999) (33)
- Systemic retinoid therapy for psoriasis. (1988) (32)
- Epidermal ornithine decarboxylase, polyamines, cell proliferation, and tumor promotion. (1980) (32)
- Comparison of treatment of acne vulgaris with alternate-day applications of tazarotene 0.1% gel and once-daily applications of adapalene 0.1% gel: a randomized trial. (2001) (32)
- Inhibition of ultraviolet-B epidermal ornithine decarboxylase induction and skin carcinogenesis in hairless mice by topical indomethacin and triamcinolone acetonide. (1982) (31)
- Association of psoriasis with HLA‐DR7 (1982) (31)
- Effects of 13-cis retinoic acid therapy on human antibody responses to defined protein antigens. (1990) (30)
- Dosing, efficacy and safety plus the use of computerized photography for botulinum toxins type A for upper facial lines (2010) (30)
- The pharmacological variability of crude coal tar (1982) (30)
- Photochemotherapy for psoriasis remission times. Psoralens and UV‐A and combined photochemotherapy with anthralin (1979) (29)
- Visual and cutaneous toxicity which occurs during N‐(4‐hydroxyphenyl) retinamide therapy for psoriasis (1986) (29)
- Linoleic acid effects on epidermal DNA synthesis and cutaneous prostaglandin levels in essential fatty acid deficiency. (1978) (29)
- Etretinate treatment for psoriasis inhibits epidermal ornithine decarboxylase. (1982) (28)
- Staphylococcal scalded skin syndrome in an adult with Hodgkin's disease. (1979) (28)
- Q-switched ruby laser. Further observations on treatment of professional tattoos. (1994) (28)
- Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis. (2006) (28)
- New retinoids for dermatologic diseases. Uses and toxicity. (1988) (27)
- Retinoic acid modulation of ultraviolet light-induced epidermal ornithine decarboxylase activity. (1982) (27)
- Pilot study to determine the efficacy of ALA‐PDT photorejuvenation for the treatment of facial ageing (2005) (27)
- Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double‐blind, randomized, parallel‐group study (2004) (27)
- Evaluation of sunscreen protection by measurement of epidermal DNA synthesis. (1980) (26)
- Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. (1989) (25)
- Serum 8-methoxypsoralen (8-MOP) concentrations after bath water delivery of 8-MOP plus UVA. (1990) (25)
- Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque‐type psoriasis (2005) (25)
- Actinic reticuloid in a black man: successful therapy with azathioprine. (1987) (24)
- New coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assay. (1982) (24)
- Palmoplantar psoriasis: experience with 8-methoxypsoralen soaks plus ultraviolet A with the use of a high-output metal halide device. (1989) (23)
- Photo(chemo)therapy: general principles. (1997) (23)
- The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin. (1987) (22)
- Differential rates of percutaneous absorption through the eczematous and normal skin of a monkey. (1986) (22)
- Ciclopirox gel for seborrheic dermatitis of the scalp (2003) (21)
- Infraorbital pigmented skin. Preliminary observations of laser therapy (1996) (21)
- Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy: reply from author (2002) (21)
- Topical drug effects on normal and proliferating epidermal cell models. (1981) (21)
- Pityriasis rubra pilaris and cyclosporine. (1993) (21)
- A report of two patients with lichen aureus. (1980) (21)
- 13‐cis‐retinoic acid for dyskeratinizing diseases—clinicopathological responses (1984) (19)
- On the need for greater regulation of medical devices. (2000) (19)
- Ultraviolet light and epidermal polyamines. (1981) (18)
- Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis. (1996) (18)
- A comparison of the efficacy and safety of the combination mometasone furoate 0.1 %/salicylic acid 5% ointment with each of its components in psoriasis (1998) (17)
- Systemic treatment of severe psoriasis--the role of cyclosporine. (1991) (17)
- Ciclopirox gel in the treatment of patients with interdigital tinea pedis (2003) (17)
- Treatment of severe psoriasis with intravenous somatostatin (1989) (17)
- Antiinflammatory drug effects on ultraviolet light-induced epidermal ornithine decarboxylase and DNA synthesis. (1980) (17)
- Mini‐Slit Graft Hair Transplantation Using the Ultrapulse Carbon Dioxide Laser Handpiece (1995) (17)
- Progress in Diseases of the Skin (1985) (16)
- Current and emerging therapeutic modalities for hyperhidrosis, part 1: conservative and noninvasive treatments. (2007) (16)
- Scrotal squamous cell carcinoma in a psoriatic patient treated with coal tar. (1986) (15)
- Textbook of Facial Rejuvenation : The Art of Minimally Invasive Combination Therapy (2002) (14)
- Fish oil consumption reduces hypertriglyceridemia in psoriatic patients receiving etretinate therapy. (1988) (14)
- Overview of botulinum neurotoxins (2007) (13)
- Botulinum Toxins for Facial Lines: A Concise Review (2012) (13)
- Subject Global Evaluation and Subject Satisfaction Using Injectable Poly-l-Lactic Acid versus Human Collagen for the Correction of Nasolabial Fold Wrinkles (2011) (13)
- Fractional radiofrequency in the treatment of skin aging: an evidence-based treatment protocol (2019) (13)
- Pharmacokinetics of topically applied radiolabeled retinoids in hairless mouse epidermis and dermis after single applications. (1985) (13)
- Courses Cutaneous surgery and laser therapyComplications of laser skin resurfacing (1998) (13)
- Essential fatty acid deficient hairless mouse: the effects of topical agents on the epidermis (1977) (13)
- Facial aesthetics: Achieving the natural, relaxed look (2007) (13)
- Extensive spinal hyperostosis in a patient receiving isotretinoin—progression after 4 years of etretinate therapy (1989) (13)
- Sunscreens and phototesting. (1988) (12)
- Home ultraviolet phototherapy. (1992) (12)
- A Phase IIa Open‐Label Dose‐Escalation Pilot Study Using Allogeneic Human Dermal Fibroblasts for Nasolabial Folds (2010) (12)
- Anti‐inflammatory properties of a prostaglandin antagonist, a corticosteroid and indomethacin in experimental contact dermatitis (1977) (12)
- Percutaneous absorption in experimental epidermal proliferation. (1978) (11)
- Investigator global evaluations of efficacy of injectable poly-L-lactic acid versus human collagen in the correction of nasolabial fold wrinkles. (2011) (11)
- A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. (1991) (11)
- U.v. wavelength dependence for the induction of ornithine decarboxylase activity in hairless mouse epidermis. (1986) (11)
- Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group. (1991) (11)
- Phototherapy units: comparison of fluorescent ultraviolet B and ultraviolet A units with a high-pressure mercury system. (1988) (10)
- Sunscreens. Update and review. (1991) (10)
- Laser and novel light source treatments for psoriasis (2004) (10)
- 3D Photography and lip filler: A novel assay (2007) (10)
- Soapr and detergent bar rinsability (1986) (10)
- NewFill for skin augmentation: a new filler or failure? (2006) (10)
- Intradermal fluorouracil and epinephrine injectable gel for treatment of psoriatic plaques. (1995) (10)
- Botulinum Toxin Type B: pH Change Reduces Injection Pain, Retains Efficacy (2014) (10)
- Systemic retinoids for psoriasis. (1995) (10)
- all‐trans‐Retinoic acid inhibits the appearance of two phorbol ester‐induced ornithine decarboxylase mRNAs in mouse epidermis (1986) (9)
- Pityriasis rubra pilaris: Etretinate shortens duration of disease (1993) (9)
- Physician's guide to sunscreens (1991) (9)
- Coexistent psoriasis and lupus erythematosus: Successful therapy with etretinate (1989) (9)
- Topical retinoids: in vivo predictive assays. (1986) (9)
- Proliferative epidermis of essential fatty acid deficient mice has reduced cyclic AMP content (1979) (9)
- Retinoids: A Clinician's Guide (1997) (9)
- Sunscreens and the prevention of skin aging. (1990) (9)
- Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study. (2004) (9)
- Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures. (2007) (8)
- Retinoid Stimulation of Epidermal Cell Growth in vivo (1985) (8)
- THE INDUCTION OF ERYTHEMA, EDEMA, and THE POLY AMINE SYNTHESIS ENZYMES ORNITHINE DECARBOXYLASE and S‐ADENOSYL‐L‐METHIONINE DECARBOXYLASE IN HAIRLESS MOUSE SKIN BY PSORALENS and LONGWAVE ULTRAVIOLET LIGHT (1984) (8)
- Peutz-Jeghers syndrome with pigmented oral papillomas. (1975) (8)
- UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines. (1991) (8)
- Comparison of topical methylaminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular basal cell carcinoma (2004) (7)
- Three-dimensional digital surface imaging measurement of the volumizing effect of injectable poly-l-lactic acid for nasolabial folds (2011) (7)
- Contribution of topical tar oil to ultraviolet B phototherapy for psoriasis. (1986) (7)
- Laser treatment of benign pigmented lesions (1997) (7)
- Epidermal polyamine profiles after multiple exposures to ultraviolet radiation. (1983) (7)
- Cutaneous phototoxicity reactions (1986) (7)
- Practical Psoriasis Therapy (1992) (7)
- Effect of forskolin on beta-adrenergic hyporesponsiveness in skin. (1988) (6)
- Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis. (1987) (6)
- Volume restoration of hands with polycaprolactone by cannula delivery; a prospective single center consecutive case series evaluation (2020) (6)
- Tazarotene versus tazarotene plus hydroquinone in the treatment of photodamaged facial skin: A multicenter, double‐blind, randomized study (2006) (6)
- Therapy of Scalp Psoriasis (1984) (6)
- Use of topical metronidazole in moderate to severe rosacea (2003) (6)
- Psoralen and ultraviolet A effects on epidermal ornithine decarboxylase induction and DNA synthesis in the hairless mouse. (1984) (6)
- Epidermal pyridoxal 5'-phosphate depletion, inhibition of DNA synthesis, and inhibition of the expression of ornithine decarboxylase activity by the vitamin B-6 antagonist 4'-deoxypyridoxine. (1983) (5)
- TRENDS IN TOPICAL PSORIASIS THERAPY (1994) (5)
- Etretinate. Appropriate use in severe psoriasis. (1988) (5)
- Erythema multiforme‐like eruptions associated with etretinate therapy (1989) (5)
- Subcutaneously Administered Efalizumab (Anti-CD 11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis (2003) (5)
- Psoriasiform dermatosis in a rhesus monkey. Epidermal labeling indexes, polyamines, and histopathologic findings. (1982) (5)
- Animal assays for anti‐psoriatic., retinoid and sunprotective agents (1984) (5)
- Microwave delivery system for lower leg telangiectasia (2000) (4)
- Quality-of-life effect of botulinum toxin type a on patients with primary axillary hyperhidrosis: results from a north american clinical study population (2004) (4)
- When Systemic Retinoids Fail to Work in Psoriasis (1991) (4)
- Dissolving unwanted submental fat (2014) (4)
- Etretinate for retinoid-responsive dermatoses: further observations of long-term therapy (1993) (4)
- On the safety of liposuction (2001) (4)
- Four methods of evaluation of facial erythema and pigment treated with intense pulsed light or cream (2012) (4)
- Psoriasis therapy: a current perspective. (1983) (4)
- Sunscreen Evaluation by Mouse Spectrophotometric and Human Assays (1986) (3)
- Periorbital Discolouration Diagnosis and Treatment: Evidence-Based Review (2020) (3)
- Factors influencing anthralin irritancy (1986) (3)
- Randomized, Placebo-Controlled Phase 1/2 Study to Determine the Appropriate ATX-101 Concentration for Reduction of Submental Fat. (2021) (3)
- Eruptive squamous cell carcinomata following psoralen‐UVA phototoxicity (1986) (3)
- Scar revision using laser: review of the literature and an appraisal (1998) (3)
- Minimally Invasive Treatments and Procedures for Ageing Skin (2010) (3)
- Short-contact anthralin therapy for psoriasis using an aqueous cream formulation. (1987) (3)
- Lichen planus: investigations of carbohydrate metabolism and the HLA system (1975) (3)
- Psoriasis: In vivo models for topical drug evaluation (1988) (3)
- A Practical Guide to Achieving Successful Outcomes with Botulinum Toxin Type A (2002) (3)
- International Experts Roundtable Proceedings Supplement (2007) (2)
- Assessment of Natural Sunlight Protection Provided by 10 High-SPF Broad-Spectrum Sunscreens and Sun-Protective Fabrics. (2021) (2)
- Newer retinoids for psoriasis--early clinical studies. (1989) (2)
- Intralesional accusiteTM-(fluorouracil/epinephrine) injectable gel for treatment of condylomata acuminata: A phase III clinical study (1994) (2)
- Vein imaging laser reduces bruising in bruise-prone botulinum toxin injected patients (2016) (2)
- The induction of prophage expression in different Salmonella typhimurium strains by DNA cross-linking and monoadduct forming psoralens and longwave ultraviolet radiation. (1983) (2)
- Woronoff's rings with PUVA therapy. (1978) (2)
- Botulinum toxins for cosmetic purposes and in the treatment of hyperhidrosis (2002) (1)
- Nonsteroidal anti-inflammatory drugs (2014) (1)
- Evidence-based recommendations for the treatment of primary axillary and palmar hyperhidrosis (2004) (1)
- Cosmetic therapy: glabellar and forehead area (2004) (1)
- Inhibition of Ultraviolet-B-Induced Epidermal Ornithine Decarboxylase and Carcinogenesis by Topical Retinoic Acid (1983) (1)
- Lasers in cutaneous and cosmetic surgery (2013) (1)
- U.S. experience of immunomodulators in the treatment of psoriasis: reply from authors (2005) (1)
- Aesthetic Uses of Botulinum Toxins (2016) (1)
- Dermatopharmacology and toxicology (1985) (1)
- Initiating Neoral® therapy (1997) (1)
- Safety of oral tazarotene in nodulocystic acne (2004) (1)
- Psoriasis ambulatory treatment centers: United States experience. (1992) (1)
- Duration of clinical improvement with oral tazarotene in plaque psoriasis (2004) (1)
- S022 Laser treatment of benign pigmented lesions (1997) (0)
- Combination with UVB (1998) (0)
- Induction of Ornithine Decarboxylase Activity and DMA Synthesis in Hairless Mouse Epidermis by Retinoids1 (2006) (0)
- Managing Your Psoriasis (1993) (0)
- N12. Psoriasis (1997) (0)
- [Retinoids--at the beginning of the second decade]. (1989) (0)
- Letters to the EditorHERPES RUGBEIORUM (1974) (0)
- Topical (bathwater) PUVA therapyy. Reply (1987) (0)
- Managing Your Psoriasis (1993) (0)
- The Rhino Mouse: Retinoid Effects on a Model of Keratin Accumulation (1986) (0)
- Tazarotene gel in combination with other topical therapies for psoriasis (1998) (0)
- Controversies in Cutaneous Surgery Laser (1999) (0)
- Editorial (2001) (0)
- Evaluation of coal tars, coal tar shampoos and body preparations (1983) (0)
- Hair growth control: Long-term results (1998) (0)
- Cyclosporine as severe psoriasis maintenance therapy in patients with (1997) (0)
- The effects of 4-deoxypyridoxine on epidermal ornithine decarboxylase, dna synthesis, and pyridoxal-5-phosphate. Abstr. (1983) (0)
- Anthralin and Chrysarobin: A Reexamination of the Origins and Early Use-Reply (1982) (0)
- Reply (1983) (0)
- Recent advances in clinical use of retinoids. (1987) (0)
- Topical Methyl Aminolevulinate (2004) (0)
- Erythemogenic doses of solar simulated UV, UVA and suberythemogenic UVA induce dramatic alterations in human skin within several months (1994) (0)
- Retinoids and Ultraviolet Induced Epidermal Ornithine Decarboxylase and Carcinogenesis (1985) (0)
- Oral retinoids. (1989) (0)
- Systemic retinoids for psoriasis : Psoriasis (1995) (0)
- Epidermal ornithine decarboxylase induction after chronic ultraviolet light radiation. Abstr. (1980) (0)
- Proceedings of the Facial and Aesthetics Conference and Exhibition, Royal College of Physicians, London, 26-27 June. (2004) (0)
- Psoriasis symposum. Retinoids. (1992) (0)
- Inductionof Mouse EpidermalOrnithineDecarboxylaseActivityand DNA Synthesisby UltravioletLight1 (1979) (0)
- Laser Hair Removal (2001) (0)
- Anthralin and Coal Tar Therapy for Psoriasis (1984) (0)
- Woronoff's Rings With PUVA Therapy-Reply (1979) (0)
- Topical tazarotene meta-analysis in acne vulgaris (2004) (0)
- Advancing Nutrient Recovery through Urine-Derived Fertilizers (UDF) in the U.S. (2018) (0)
- Time course of inflammation and depletion of glutathione after psoralen and ultraviolet light-a. Abstr. (1983) (0)
- RETINOIDS AND MALIGNANCY (1987) (0)
- Botulinum toxin type a in primary axillary hyperhidrosis: a 52-week, multicenter, double-blind, randomized, placebo-controlled trial1 (2004) (0)
- Tazarotene plus UVB phototherapy: Efficacy and tolerability in psoriasis (1998) (0)
- Radiofrequency Devices Including Fractional Radiofrequency (2020) (0)
- Reply to Letter by Rupa & Monk (2003) (0)
- Editorial (2002) (0)
- Phototherapy and dithranol treatment of psoriasis. (1987) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nicholas J. Lowe?
Nicholas J. Lowe is affiliated with the following schools:
